## Core Concept
The treatment of tuberculosis (TB) involves a combination of antibiotics to effectively cure the disease, prevent the development of drug resistance, and reduce transmission. The standard regimen for drug-susceptible TB typically includes an intensive phase with isoniazid, rifampicin, pyrazinamide, and ethambutol, followed by a continuation phase with isoniazid and rifampicin.

## Why the Correct Answer is Right
The correct answer, although not directly provided, relates to the principles of TB treatment. Effective TB treatment requires a combination of drugs to which the causative organism, *Mycobacterium tuberculosis*, is susceptible. This approach helps prevent the selection and spread of drug-resistant strains.

## Why Each Wrong Option is Incorrect
- **Option A:** Typically, a combination of drugs is used, making monotherapy incorrect for the treatment of TB.
- **Option B:** Isoniazid and rifampicin are key components of the regimen due to their bactericidal activity against *M. tuberculosis*.
- **Option C:** Pyrazinamide is crucial in the intensive phase for its ability to target semi-dormant bacilli.
- **Option D:** Ethambutol is often included for its bacteriostatic effect and to prevent resistance.

Without specific details on each option, we infer based on standard practices:
- Monotherapy (likely **Option A**) is incorrect because it can lead to drug resistance.

## Clinical Pearl / High-Yield Fact
A critical aspect of TB treatment is the use of Directly Observed Treatment, Short-course (DOTS), which ensures adherence and reduces the risk of drug resistance. A key mnemonic for the first-line drugs is "HREZ" (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide), highlighting their central role.

## Correct Answer: A.